Endocyte EV to EBITDA (TTM)
Endocyte EV to EBITDA (TTM) Chart
Endocyte Historical EV to EBITDA (TTM) Data
| Data for this Date Range | |
|---|---|
| March 30, 2015 | Upgrade |
| March 27, 2015 | Upgrade |
| March 26, 2015 | Upgrade |
| March 25, 2015 | Upgrade |
| March 24, 2015 | Upgrade |
| March 23, 2015 | Upgrade |
| March 20, 2015 | Upgrade |
| March 19, 2015 | Upgrade |
| March 18, 2015 | Upgrade |
| March 17, 2015 | Upgrade |
| March 16, 2015 | Upgrade |
| March 13, 2015 | Upgrade |
| March 12, 2015 | Upgrade |
| March 11, 2015 | Upgrade |
| March 10, 2015 | Upgrade |
| March 9, 2015 | Upgrade |
| March 6, 2015 | Upgrade |
| March 5, 2015 | Upgrade |
| March 4, 2015 | Upgrade |
| March 3, 2015 | Upgrade |
| March 2, 2015 | Upgrade |
| Feb. 27, 2015 | Upgrade |
| Feb. 26, 2015 | Upgrade |
| Feb. 25, 2015 | Upgrade |
| Feb. 24, 2015 | Upgrade |
| Feb. 23, 2015 | Upgrade |
| Feb. 20, 2015 | Upgrade |
| Feb. 19, 2015 | Upgrade |
| Feb. 18, 2015 | Upgrade |
| Feb. 17, 2015 | Upgrade |
| Feb. 13, 2015 | Upgrade |
| Feb. 12, 2015 | Upgrade |
| Feb. 11, 2015 | Upgrade |
| Feb. 10, 2015 | Upgrade |
| Feb. 9, 2015 | Upgrade |
| Feb. 6, 2015 | Upgrade |
| Feb. 5, 2015 | Upgrade |
| Feb. 4, 2015 | Upgrade |
| Feb. 3, 2015 | Upgrade |
| Feb. 2, 2015 | Upgrade |
| Jan. 30, 2015 | Upgrade |
| Jan. 29, 2015 | Upgrade |
| Jan. 28, 2015 | Upgrade |
| Jan. 27, 2015 | Upgrade |
| Jan. 26, 2015 | Upgrade |
| Jan. 23, 2015 | Upgrade |
| Jan. 22, 2015 | Upgrade |
| Jan. 21, 2015 | Upgrade |
| Jan. 20, 2015 | Upgrade |
| Jan. 16, 2015 | Upgrade |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About EV / EBITDA
EV/EBITDA is the enterprise value of a company divided by its earnings before interest, taxes, depreciation and amortization. (EV/EBITDA)
EV/EBITDA answers the question "What is a company being valued per each dollar of EBITDA?" A high (low) EV/EBITDA mean the company is potentially overvalued (undervalued).
EV/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.
Other similar metrics include :
EV/Revenues: How much is each dollar of revenues worth to investors?
EV/EBIT : Or each dollar of EBIT?
EV/Free Cash Flow : Or each dollar of FCF?
For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More
View EV to EBITDA (TTM) for ECYT
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.
Start My Free Trial
No credit card required.
Already a subscriber? Sign in.
ECYT EV to EBITDA (TTM) Benchmarks
| Companies | |
|---|---|
| Immune Design | Upgrade |
| Achillion Pharmaceuticals | Upgrade |
| Cytokinetics | Upgrade |
ECYT EV to EBITDA (TTM) Range, Past 5 Years
| Minimum | Upgrade | Oct 10 2014 |
| Maximum | Upgrade | Mar 04 2015 |
| Average | Upgrade |
ECYT EV to EBITDA (TTM) Excel Add-In Codes
- Metric Code: ev_ebitda
- Latest data point: =YCP("ECYT", "ev_ebitda")
- Last 5 data points: =YCS("ECYT", "ev_ebitda", -4)
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
ECYT News
PR Newswire 09/15 07:05 ET
Globe Newswire 09/05 16:01 ET
Globe Newswire 08/16 08:00 ET
PR Newswire 08/10 07:05 ET
